Climb Bio, Inc.
- CLYM
- NASDAQ
- Biotechnology
- Autoimmune Disease Therapy
- Antibody Therapeutics (anti-CD19)
$9.82
Today −9.99%Quote Oct 16, 2026, 08:00 PM UTC
−30.16%over the last month
Max drawdown −30.9%From 1-month high −30.9%3 months −19.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$564.0M
Quote Oct 16
Next earnings
Nov 11
Expected, not confirmed
Analyst target
$28.00
+185.1% from here
Floor
$9.38
4.4% below price
Where the price sits
7 analysts
Analyst range, low to high
$17.00$40.00
- Price $9.82
- Resistance $9.83
- Consensus $28.00
The price is right under resistance. Analysts' average target sits about 185% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about CLYMPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
28